Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_assertion type Assertion NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_head.
- NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_assertion description "[Oral administration of penta-O-galloyl-?-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_provenance.
- NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_assertion evidence source_evidence_literature NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_provenance.
- NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_assertion SIO_000772 21289371 NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_provenance.
- NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_assertion wasDerivedFrom befree-20140225 NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_provenance.
- NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_assertion wasGeneratedBy ECO_0000203 NP660756.RAQPZ1uxNrFrg80DIHLm9WGtZd4Y1-kepCpebniXPITWA130_provenance.